196 related articles for article (PubMed ID: 15839057)
1. [Risk of acquisition of RFP resistance out of INH resistant RFP susceptible tuberculosis].
Yoshiyama T; Ito K; Ogata H; Aono A; Wada M
Kekkaku; 2005 Jan; 80(1):9-14. PubMed ID: 15839057
[TBL] [Abstract][Full Text] [Related]
2. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
Yoshiyama T; Ogata H; Ito K; Aono A; Wada M
Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
4. [Process of acquiring drug resistance: retrospective review of records of MDR TB].
Yoshiyama T; Ito K; Ogata H; Mitarai S; Hoshino H; Okumura M; Aman K; Aono A; Wada M
Kekkaku; 2004 Dec; 79(12):717-24. PubMed ID: 15782617
[TBL] [Abstract][Full Text] [Related]
5. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
[TBL] [Abstract][Full Text] [Related]
6. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes.
Yoshiyama T; Yanai H; Rhiengtong D; Palittapongarnpim P; Nampaisan O; Supawitkul S; Uthaivorawit W; Mori T
Int J Tuberc Lung Dis; 2004 Jan; 8(1):31-8. PubMed ID: 14974743
[TBL] [Abstract][Full Text] [Related]
7. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].
Shigetoh E; Murakami I; Yokosaki Y; Kurimoto N
Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128
[TBL] [Abstract][Full Text] [Related]
8. Preventing drug-resistant tuberculosis with a fixed dose combination of isoniazid and rifampin.
Moulding TS; Le HQ; Rikleen D; Davidson P
Int J Tuberc Lung Dis; 2004 Jun; 8(6):743-8. PubMed ID: 15182145
[TBL] [Abstract][Full Text] [Related]
9. [Epidemiological survey on the trend of drug resistance of Mycobacterium tuberculosis complex in Macao during 2001 to 2005].
Cheong SV; Lao UL
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):411-4. PubMed ID: 17673010
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
11. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
Migliori GB; Espinal M; Danilova ID; Punga VV; Grzemska M; Raviglione MC
Int J Tuberc Lung Dis; 2002 Oct; 6(10):858-64. PubMed ID: 12365571
[TBL] [Abstract][Full Text] [Related]
12. [A case of drug-resistant pulmonary tuberculosis treated successfully following disappearance of rifampicin resistance after 17 years' chemotherapy].
Shigeto E; Murakami I; Yokosaki Y
Kekkaku; 2001 Apr; 76(4):379-83. PubMed ID: 11398329
[TBL] [Abstract][Full Text] [Related]
13. [Studies on the problems of resistance to antituberculous drugs. II--1. Clinically applicable criteria of drug-resistance to rifampicin].
Baba H
Kekkaku; 1994 Jun; 69(6):387-96. PubMed ID: 8041057
[TBL] [Abstract][Full Text] [Related]
14. [Effects of two treatment regimens for drug-resistant tuberculosis in tuberculosis control project areas: a comparative study].
Li L; Zheng SH; Chu NH; Xie YG; Yang YZ; Li Q; Wang XM; Yan XL; Tan WG; Miao ZP; Duanmu HJ
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3387-91. PubMed ID: 19159566
[TBL] [Abstract][Full Text] [Related]
15. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
[TBL] [Abstract][Full Text] [Related]
16. [Anti-tuberculosis chemotherapy].
Wada M
Kekkaku; 2007 Oct; 82(10):771-81. PubMed ID: 18018601
[TBL] [Abstract][Full Text] [Related]
17. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.
Park SK; Kim CT; Song SD
Int J Tuberc Lung Dis; 1998 Nov; 2(11):877-84. PubMed ID: 9848607
[TBL] [Abstract][Full Text] [Related]
18. [Retreatment of pulmonary tuberculosis--duration of chemotherapy].
Wada M; Seita A; Mori T; Ogata H; Sugie T; Sugita H
Kekkaku; 1993 Jul; 68(7):469-78. PubMed ID: 8361115
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of bactec MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid].
Mitarai S; Kobayashi I; Abe C; Wada M; Suzuki K; Takashima T; Kawabe Y; Machida K; Tano M; Takigawa S; Kamada A; Shigetoh E; Fujii S; Mori K; Suyama H; Yano S; Kawashiro T; Ogata H
Kekkaku; 2007 May; 82(5):449-54. PubMed ID: 17564123
[TBL] [Abstract][Full Text] [Related]
20. [Frequency of MDR-TB/XDR-TB strains isolated from chronic pulmonary tuberculosis patients in Japan].
Kazumi Y; Itagaki N; Ohmori M; Wada M; Hoshino H; Mitarai S; Sugawara I; Ishikawa N; Mori T
Kekkaku; 2007 Dec; 82(12):891-6. PubMed ID: 18188977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
